Tendency for Varicose Vein Formation in Pregnancy by Sastrawinata, U. S. (Ucke)
  1
 
Tendency For Varicose Vein Formation In Pregnancy 
 
Ucke Sugeng Sastrawinata 
Department Of Obstetrics and Gynecology, Maranatha Christian University 
Immanuel Hospital, Bandung 
 
 
 
Abstract 
Varicoses remains an important issue related to obstetrics since pregnancy is one of the leading 
factors causing varicoses in women. Physiological complex and hormonal changes in pregnancy cause 
veins distension followed by valves dysfunction, endothelial injury marked by the increase of soluble 
Vascular Cell Adhesion Molecules-1 (VCAM-1) in the circulation, and supported by femoral and great 
saphenous veins dilatation and reflux in the saphenous-femoral junction. The objectives of this study are to 
examine the possibility to use measurements of soluble VCAM-1, levels of platelet activations, alterations 
in veins structure and function of lower limbs veins as early detection methods to reduce the risk of 
varicoses in primigravida wearing elastic stockings with mechanical compression. A prospective study was 
performed in a randomized single blinded trial with analysis of variance and repeated measures. The study 
was done at The Obstetric and Gynaecology Department Immanuel Hospital Bandung, with subjects 
obtained from the Obstetrics outpatient clinic and Astana Anyar Maternity Hospital Bandung during the 
period of May 2005 to March 2006. This study consisted of a population of 66 primigravida randomly 
allocated in to 2 groups, 34 women in control group and 32 women in study group. Women in the study 
group were instructed to wear elastic stockings, while the control group was not. Measurements of 
VCAM-1 were performed using ELISA (Enzyme-Linked Immunosorbent Assay). Measurements of veins 
dilatation were carried out using a Color Duplex Ultrasound. Levels of platelet aggregation were 
measured with a platelet aggregometer. Examination of 12 weeks and 34 weeks gestational age showed the 
average of VCAM-1 concentrations in the control group were increased as high as 194,6 ± 113,6 ng/ml 
compared to 82,5 ± 65,3 ng/ml in the study group. The study group also has less dilatated left femoral 
veins and great saphenouns veins (subsequently 0,83 ± 0,07 cm and 0,83 ± 0,07 cm) compared to control 
group (subsequently 1,02 ± 0,35 cm and 1,01 ± 0,35 cm).Tthe incidence of reflux was found only in the 
study group at sapheno-femoral junction in 6 of 34 women. Alterations in platelets aggregations and 
count were found not statistically significant in both groups, indicating the process occurred locally and 
had a minimal effect in the alterations of platelets activation profile. 
In conclusions, our findings suggest that, the pathogenesis of varicoses started from excessive 
increase in diameter of lower limbs and pelvic veins, resulting  the endothelial injury and followed by the 
increase of soluble VCAM-1 expression. Mechanical compression provide protective effect from the 
development of varicoses shown by the reduced VCAM-1 expression, reduced incidence in developing 
reflux in blood flow in saphenous-femoral junction, in addition to minimal dilatation of the lower limbs 
and pelvic veins. 
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Introduction 
Varicoses becoming a more 
important issue lately since they cause 
many aesthetic problems and most 
importantly causing legs discomfort. A 
serious complication may also follow 
untreated varicoses such as thrombosis. 
Varicoses occur as a result of veins 
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distention marked with the appearance 
of enlarged and elongated veins1,2. There 
are several predisposing factors that may 
contribute to the occurrence of varicoses 
in females. These factors are including 
genetic factors, old age, the usage of 
hormonal contraception, obesity, 
activities which require a long time to 
stand still, and most importantly is 
pregnancy2.  
 Although varicoses is not 
included in the three main causes of 
Maternal Death, varicoses remains an 
important aspect that reduces women’s 
productivity and life quality. Varicoses 
cause leg discomforts, pain, and 
aesthetics problems which may require 
high cost treatments including vascular 
surgery therapies3-5. 
 Studies in determining the 
varicoses prevalence and its 
complications have never been 
conducted in Indonesia. However, there 
was found a difference in varicoses 
prevalence between white females (49%) 
compared to Asian females (36%) which 
lead to an assumption that death as a 
complication of varicoses is also lower in 
Asia than those in Western countries6. 
Based on studies carried out in Europe it 
was shown that during the first 
pregnancy (primigravida) the incidence 
of varicoses occurrence was as high as 
30-35%. This relatively high number also 
contributes to the higher risk of 
developing varicoses in the subsequent 
pregnancy or even after menopause6-8. 
  
 
Materials And Methods 
 This study was performed in a 
randomized single blinded trial with 
analysis of variance and repeated 
measures.  
 
 
Results and Discussions 
This study consisted of a 
population of 66 primigravida randomly 
allocated in to 2 groups, 34 women in 
control group and 32 women in study 
group. Women in the study group were 
instructed to wear elastic stockings, 
while the control group was not. 
As shown on table 1, based on 
the age, body mass index, VCAM-1 
levels, and platelets aggregation profiles 
there were no significant differences 
among non-pregnant and the 
primigravida on the first 12 weeks of 
pregnancy. Therefore these data also 
showed only minimal changes occuring 
during the first 12 weeks of pregnancy 
and thus eliminate the possibility of 
results bias. 
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75  females 
(primigravida) 
38 treated 
(stockings) 
37 untreated 
(without stockings) 
30 females  
(non-pregnant) 
1st observation (12 weeks pregnancy) 
Delivery
Randomized 
Inclusion criteria
Note: 
1st, 2nd 3rd observations: 
- VCAM-1 levels 
- Platelets activity 
- Measurements and functional study 
of  lower limbs and pelvic veins 
Inclusion criteria
Observations 
2nd observations (34 weeks pregnancy) 
3rd observations (2 weeks post delivery) 
Primigravida 
Research flow chart
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Table 1   Comparisons of individual characteristics (Age, Body Mass Index), VCAM-1 
levels, and platelets aggregations among the three groups 
 
No 
 
Variables 
Groups  
Significance Treated 
(n=32) 
Untreated 
(n=34) 
Non-
pregnant  
(n=30) 
1. Age (years)     
 x (SD) 25.0 (3.3) 25.0 (3.7) 25.7 (2.3) F=0.501 
 Range 20-30 20-30 20-30 p=0.685 
2. Body Mass Index 
(kg/m2) 
    
 x (SD) 22.7 (2.2) 23.0 (1.7) 22.6 (2.2) F=0.399 
 Range 19.8-26 19.8-26 19.8-26 p=0.672 
3. VCAM-1 (ng/ml)     
 x (SD) 357.3 (162.1) 361.4 (113.5) 362.2 (153.7) Χ2K-W=0.176 
 Median 341.6 329 341.6 p=0.916 
 Range 102.8-841.4 202-540.2 102.8-841.4  
4. Platelets aggregations     
 Hiper 9 (28.1) 12 (35.3) 10 (33.3) Χ2=0.553 
 Hipo 3 (9.4) 3 (8.8) 2 (6.7) p=0.968 
 Normo 20 (62.5) 19 (55.9) 18 (60.0)  
5. Platelets aggregations 
(%) 
    
 x (SD) 63.8 (8.2) 64.2 (7.3) 64.4 (7.6) Χ2K-W=0.231 
 Median 65.8 65.3 66 p=0.891 
 Range 45.3-78.2 47.3-75.3 45.3-76.3  
Note: 
F = variants analysis 
X2 K – W = chi square test (Kruskal – Wallis) 
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Table 2.  Comparisons of lower limbs and pelvic veins diameters during the 1st 12 
weeks of pregnancy  
 
No. 
 
Variables 
Groups  
Χ2K-W 
 
P 
value 
Treated 
(n=32) 
Untreated 
(n=34) 
Non-pregnant 
(n=30) 
1. Left femoral veins     0.745 0.689 
 x (SD) 0.80 (0.07) 0.81 (0.06) 0.81 (0.07)   
 Median 0.79 0.79 0.82   
 Range 0.64-0.92 0.64-0.92 0.64-0.92   
2. Right femoral veins    5.10 0.078 
 x (SD) 0.79 (0.07) 0.76 (0.07) 0.81 (0.07)   
 Median 0.78 0.76 0.80   
 Range 0.64-0.92 0.60-0.92 0.64-0.92   
3. Left greater 
saphenous veins  
   1.148 0.563 
 x (SD) 0.80 (0.07) 0.81 (0.07) 0.82 (0.07)   
 Median 0.80 0.78 0.83   
 Range 0.64-0.93 0.64-0.95 0.64-0.92   
4. Right greater 
saphenous veins 
   4.844 0.089 
 x (SD) 0.79 (0.07) 0.77 (0.06) 0.79 (0.07)   
 Median 0.78 0.76 0.78   
 Range 0.64-0.92 0.65-0.93 0.64-0.92   
5. Left popliteal veins     1.006 0.605 
 x (SD) 0.80 (0.07) 0.80 (0.06) 0.81 (0.07)   
 Median 0.79 0.78 0.79   
 Range 0.62-0.92 0.64-0.92 0.62-0.94   
6. Right popliteal veins    3.045 0.218 
 x (SD) 0.79 (0.07) 0.77 (0.06) 0.79 (0.07)   
 Median 0.78 0.76 0.78   
 Range 0.64-0.92 0.60-0.92 0.64-0.92   
7. Left external iliac veins     0.197 0.906 
 x (SD) 0.80 (0.07) 0.80 (0.07)  0.80 (0.07)   
 Median 0.79 0.79 0.79   
 Range 0.64-0.92 0.64-0.92 0.64-0.93   
8. Right external iliac 
veins 
   4.744 0.093 
 x (SD) 0.79 (0.07) 0.80 (0.07) 0.80 (0.07)   
 Median 0.78 0.76 0.78   
 Range 0.64-0.92 0.60-0.92 0.63-0.92   
Note: Measurements were in centimetres 
 X2 K – W = chi square test (Kruskal – Wallis) 
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Table 3. VCAM-1 levels between treated and untreated groups 
 
No 
 
Variables 
Groups  
ZM-W 
 
P value Treated 
(n=32) 
Untreated 
(n=34) 
1. VCAM-1 ( I )     
 x (SD) 357.3(162.1) 361.4(113.5) 0.208 0.649 
 Median 341.6 329   
 Range 102.8 – 841.4 202 -540.2   
2. VCAM-1 ( II )     
 x (SD) 439.8 (171.6) 556.0 (130.4) 8.040 0.005 
 Median 440.2 555.6   
 Range 126 - 897.2 307.4 -970.6   
3. VCAM-1 ( III )     
 x (SD) 556.4 (243.8) 753.9 (260.8) 12.814 < 0.001 
 Median 529.3 696.6   
 Range 206.8 – 1179 449 - 1662.4   
Note: 
VCAM-1 levels were in ng/ml 
ZM-W = Mann-Whitney Test 
I  : Observations during the 12 weeks of pregnancy 
II : Observations during the 34 weeks of pregnancy 
III: Observations during the 2 weeks post delivery 
The average value for VCAM-1 levels in the non-pregnant females were 362.2 (153.7) ng/ml 
 
 
Table 4. Comparisons of platelets aggregation profiles between treated and untreated 
groups  
 
No 
 
Variables 
Groups  
P value  Treated 
(n=32) 
Untreated 
(n=34) 
1. Platelets aggregation ( I )    
 Hiper 9 (28.1) 12 (35.3) 0.821 
 Hipo 3 (9.4) 3 (8.8)  
 Normo 20 (62.5) 19 (55.9)  
2. Platelets aggregation ( II )    
 Hiper 12 (35.3) 16 (47.1) 0.401 
 Hipo 4 (11.8) 4 (11.8)  
 Normo 18 (52.9) 14 (41.2)  
3. Platelets aggregation ( III )    
 Hiper 15 (44.1) 18 (52.9) 0.479 
 Hipo 4 (11.8) 5 (14.7)  
 Normo 15 (44.1) 11 (32.4)  
Note:  
I  : Observations during the 12 weeks of pregnancy 
II : Observations during the 34 weeks of pregnancy 
III: Observations during the 2 weeks post delivery 
P value were calculated based on chi square test 
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Table 3 shows that although 
there were no significant differences 
during the 12 weeks of pregnancy 
between the treated and untreated 
groups, there was a significant difference 
in the increased VCAM-1 levels during 
the 34 weeks pregnancy between the two 
groups (p = 0.005). The difference was 
even greater during the 2 weeks post 
delivery (p < 0.001). 
During the 1st 12 weeks of 
pregnancy, VCAM-1 levels were 
comparable to the non-pregnant 
individuals and have not yet increased. 
VCAM-1 levels were gradually 
increased with the progression of the 
pregnancy (as detected at 34 weeks) as 
the uterus started to cause pressure of 
the pelvic veins. Subsequently, the 
pressure result in the increasing 
distention of pelvic and lower limbs 
veins, causing endothelial injury marked 
by the increasing levels of VCAM-1.9-11 A 
venographic study of pregnant women 
during the last 3rd semester has shown a 
narrowing of the Inferior vena cava12-13. 
Moreover, there was a reduced velocity 
of blood flow in the femoral veins in 
accordance with the enlargement of the 
uterus particularly during the last 
trimester of pregnancy14. The increased 
levels of progesterone and estrogen 
during the pregnancy also contributed in 
the vein dilatation, as progesterone has 
been known to have an effect in 
decreasing smooth muscle tension 
including vein’s endothelial walls thus 
causing further veins dilatations even up 
to 150% throughout the pregnancy15-18. 
The veins dilatation only started to 
return normally within 8-12 weeks post 
delivery18-19. 
VCAM-1 levels found in the 
treated group were not as elevated as in 
the untreated group. These data 
suggested that excessive endothelial 
injury and distention of the veins were 
able to be prevented by the usage of 
elastic stockings10-12. Moreover, a 
significant difference in the VCAM-1 
levels during the 2 weeks post delivery 
revealed not only that the usage of 
elastic stockings prevent further 
distention of the veins, but also 
contribute in the more rapid healing 
process of the endothelial injury13-18. 
The increasing levels of VCAM-
1 during the pregnancy were found to be 
not as high as in patients with eclampsia. 
This finding suggest that the endothelial 
injury in varicoses is restricted compared 
to the eclampsia where the massive 
endothelial injury presents 
systemically19-20. Furthermore, in a study 
performed by Scurr dan Sparey, it was 
shown that a decrease in the velocity of 
blood flow within the veins did not 
cause a massive endothelial injury 
compared to the endothelial injury 
within the arteries21-23. 
As shown on Table 4, platelets 
aggregation profiles were not 
significantly altered among the groups 
of treated, untreated, during the 12 
weeks, 34 weeks of pregnancy, and 2 
weeks post delivery. The slight increase 
in the platelets aggregation profile due 
to the presence of the veins endothelial 
injury was apparently not significant (P 
value > 0.01). 
As shown on Table 5, there were 
no significant differences in the diameter 
of left femoral veins between the treated 
and untreated group during the 12 
weeks of pregnancy. However, there 
were a significant increase in the 
diameter of left femoral veins during the 
34 weeks of pregnancy  (p < 0.001) as 
well as during the 2 weeks post delivery 
(p <0.001) between the treated and 
untreated groups. The left femoral veins 
diameter in the untreated group were 
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significantly less dilated compared to 
those in the untreated group. 
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Table 5. Comparisons of Left and Right femoral veins diameters in treated and 
untreated groups  
 
No. 
 
Femoral 
veins 
 
Observations 
Groups  
ZM-W 
 
P value Treated 
(n=32) 
Untreated 
(n=34) 
1. Left I   0.161 0.872 
  x (SD) 0.80 (0.07) 0.81 (0.07)   
  Median 0.79 0.79   
  Range 0.64-0.92 0.64-0.92   
  II   3.477 <0.001 
  x (SD) 0.83 (0.07) 1.02 (0.35)   
  Median 0.82 0.89   
  Range 0.69-1.0 0.78-1.95   
  III   5.276 <0.001 
  x (SD) 0.90 (0.30) 1.30 (0.68)   
  Median 0.82 1.00   
  Range 0.5-1.91 0.85-3.03   
2. Right I   1.757 0.079 
  x (SD) 0.79 (0.07) 0.76 (0.07)   
  Median 0.78 0.76   
  Range 0.64-0.92 0.60-0.92   
  II   3.163 0.002 
  x (SD) 0.84 (0.09) 0.88 (0.05)   
  Median 0.82 0.89   
  Range 0.72-1.23 0.78-0.99   
  III   5.060 <0.001 
  x (SD) 0.88 (0.26) 0.99 (0.11)   
  Median 0.82 0.98   
  Range 0.69-1.71 0.85-1.52   
Note: 
Measurements of vein diameters were in centimeters 
ZM-W = Mann-Whitney Test 
I  : Observations during the 12 weeks of pregnancy 
II : Observations during the 34 weeks of pregnancy 
III: Observations during the 2 weeks post delivery 
The average diameter of Femoral veins in the non-pregnant females were (left) 0.81(0.07) cm and (right) 
0.81(0.07) cm 
 
 
Starting from the beginning of 
the 12 weeks of pregnancy plasma 
volume is slightly increased, whereas 
from the 24 weeks onwards it is 
increasing enormously until its peak at 
around 34 weeks18. The increasing 
pressure caused by the enlarged uterus 
causes a raise in the internal pressure 
within the pelvic veins which 
subsequently was followed by the 
increased pressure within the lower 
limbs veins resulting in distention of the 
veins. Without any adequate treatments 
this process will result in varicoses21-24. 
 
 
Conclusions  
Generalized Conclusions 
1. The untreated group of 
primigravida which was not 
wearing elastic stockings had 
significantly larger veins diameter 
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compared to the treated group 
wearing elastic stockings 
2. The incidence of reflux blood flow 
was only found in the untreated 
group. 
3. The increased levels of VCAM-1 in 
the untreated primigravida were 
significantly higher than the treated 
group. 
4. There was no significantly difference 
in platelets aggregation profiles 
between treated and untreated 
groups. 
 
 
Specified Conclusions 
1. The progression of varicoses is 
marked by increased levels of 
VCAM-1 as a result of endothelial 
injury in the distended veins and 
valve dysfunction.  
2. There is a strong correlation between 
the veins dilatation and the levels of 
endothelial injuries, shown by the 
increase of VCAM-1 in accordance 
with the increasing veins dilatation. 
3. Primigravida with level of VCAM-1 
higher than 478 ng/ml have a 2.67 
increase risk in developing varicoses 
(with 71.2% confidence) compared to 
those with lower levels of VCAM-1.  
4. Primigravida with level of VCAM-1 
higher than 478 ng/ml without 
elastic stockings will have an 
increased risk to develop varicoses 
as high as 41.9% compared to those 
wearing elastic stockings. 
5. In this study, it was found that 
reflux in the sapheno-femoral junction 
occurred in 6 cases (17.6%) of the 
untreated group and among them 2 
cases (5.9%) were permanently 
present until 2 weeks post delivery. 
6. Mild varicoses never occurred in the 
treated group, on the other hand 3 
cases of mild varicoses were found 
in the untreated group and found to 
persist until 2 weeks post delivery. 
7. There was a significant difference in 
the dilatations of femoral veins 
between the cases with reflux and 
without reflux (p < 0.032). 
 
Theoretically, there are many 
predisposing factor in the development 
of varicoses in females. However this 
study has shown that most importantly, 
the initiation of varicoses was started by 
the presence of veins dilatations which 
then caused endothelial injury marked 
by increased levels of VCAM-1. The 
usage of elastic stockings has shown to 
significantly reduce the dilatation of 
lower limbs and pelvic veins, thus 
reducing excessive endothelial injury 
marked by lower levels VCAM-1. This 
treatment is shown to effectively prevent 
the risk of varicoses developments in 
pregnancy. Another essential finding 
shown in this study was that platelets 
aggregation profiles were not 
significantly altered following the 
endothelial injury in the development of 
varicoses21-24. 
 
 
Suggestions and Recommendations  
Several suggestions proposed based on 
this study are as follow: 
1. Academically 
1.1. Further studies are required to 
distinguish the main cause of 
lower limbs and pelvic veins 
dilatation as the initial process 
in the development of varicoses 
in pregnancy. 
1.2. Further studies are also 
required to determine other 
vaso-active components 
present in veins endothelial 
injury. 
 
Tendency For Varicose Vein Formation In Pregnancy 
(Ucke Sugeng Sastrawinata) 
 11
1.3. Further studies are required to 
elucidate the incidence of 
varicoses in subsequent 
pregnancy up to menopause in 
a population of studied 
primigravida wearing elastic 
stockings. 
2. Practically 
2.1. It is suggested that all pregnant 
women should wear elastic 
stockings starting from their 1st 
pregnancy no later than 12 
weeks of pregnancy to reduce 
the risk of varicoses 
development. 
2.2. Individuals with risks to 
develop varicoses during 
pregnancy are recommended to 
wear elastic stockings as early 
as 12 weeks of pregnancy. 
2.3. The Colour Duplex Ultrasound 
examination is particularly 
useful to distinguish the 
varicoses progression from 
other causes in primigravida 
with VCAM-1 levels higher 
than 478 ng/ml. 
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